HIV Management: An Update on the Latest EACS Guidelines

Slides:

Advertisements

Similar presentations

Management of ART in Albania : From the European Guidelines to the real practice. Arjan Harxhi MD, MSc, PhD University Hospital Center of Tirana Mother.

Advertisements

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.

BORDERNETwork Training on HIV and HBV Co-Infections Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A.

Hepatitis web study Hepatitis web study Peginterferon alfa-2b + RBV versus Interferon alfa-2b RIBAVIC STUDY Phase 3 Treatment Naïve, Chronic HCV and HIV.

N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER 2014 IAS-USA Treatment Guidelines Brian R. Wood, MD Medical Director, NW AETC ECHO Assistant Professor.

BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.

When to Initiate ART in Adults and Adolescents (2009 WHO Guidelines) Target PopulationClinical conditionRecommendation Asymptomatic Individuals (including.

2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.

BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.

N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.

Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.

Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati,

Treatment of HBV/HCV Coinfection

Phase 3 Treatment Experienced

Hepatitis C Consultation Services (844) | 9AM-5PM ET, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert clinical.

Treatment-Naïve Adults

Where Are We on the Path to Elimination of Chronic Hepatitis C?

EASL Recommendations on Treatment of Hepatitis C 2015 Treatment recommendations for HCV-monoinfected or HCV/HIV coinfected patients with chronic hepatitis.

Lesson 2: Special Considerations When Treating HIV/HCV Co-infection

Phase 3 Treatment-Naïve and Treatment-Experienced

Phase 3b Treatment-Naive

Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir in GT1b TURQUOISE-III

Phase 2 Treatment Naïve HIV Coinfection

Hepatitis C Consultation Services (844) | 9AM-8PM EST, M-F nccc.ucsf.edu The Clinician Consultation Center (CCC) provides up-to-date expert advice.

Chronic Hepatitis C Virus Infection

Managing Women Living With HIV Infection

HCV: Who Should We Screen and Why?

Introduction. Looking Beyond HIV Infection: CCR5 Blockade as an Immunomodulatory Concept

Case 53-year-old Black Man

HCV Infection in the United States: What Are We Dealing With?

Program Goals Overview of HIV Epidemic HIV and Communities of Color.

The Patient Journey to Remission in MDD: A Collaborative Approach

Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?

The Latest Data on Oral Prostacyclin Therapy in PAH

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

More Than Treatment.

What Would You Do in This Case of MDD?

Phase 3 Treatment Naïve HIV Coinfection

Translating Emerging HIV Data Into Clinical Practice

PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Program Overview. Why, When, and How to Switch ART in Patients With HIV Who Have Achieved Viral Suppression.

Is it Time for a Paradigm Change in HIV Management?

HIV : New Agents, New Strategies

Personalizing Statin Therapy in Patients With HIV

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

Examining the Latest Evidence in PAH

When to Start and What to Use

Phase 3 Treatment Naïve and Treatment Experienced HIV Coinfection

The Road to Quality Improvement in HER2-Positive Breast Cancer

When Is Intrathecal Drug Delivery Appropriate?

Hepatitis C: After the Diagnosis

A Guideline-Based Approach to HCV Care

HIV Update 2018: A Front Row Seat

Phase 2 Treatment Naïve Elbasvir-Grazoprevir + Sofosbuvir in Treatment-Naïve HCV Genotype 1 or 3 C-SWIFT Poordad F, et al. EASL 2015; Abstract O006.

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

What Does the Future Hold and What Will It Mean for Patients?

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Phase 3 Treatment-Naïve and Treatment-Experienced

When Is Intrathecal Drug Delivery Appropriate?

Phase 3 Treatment-Naïve and Treatment-Experienced

Binge Eating Disorder.

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Lesson 2: Special Considerations When Treating HIV/HCV Co-infection

Phase 3 Treatment-Naïve and Treatment-Experienced

Diagnosis and Management of HIV-2 in Adults

The IAS TB/HIV Research Prizes are awarded to:

Presentation transcript:

HIV Management: An Update on the Latest EACS Guidelines

Program Objectives

How the Guidelines Are Organized

Recommendations for ART Initiation in HIV-positive Patients With Chronic Infection Without Prior ART Exposure

ART in EACS guidelines

Treatment of Primary HIV Infection

Initial Combination Regimen for ART-Naive HIV-positive Adults

Alternative Regimens

Switch Strategies for Virologically- Suppressed Patient

IPERGAY Trial: PrEP

Prevention and Management of Comorbidities in HIV-positive Persons

Drug-Drug Interactions Between Contraceptives/Hormone Replacement Therapy and ART

Prevention

Cancer: Screening Methods

Algorithm for Diagnosis of HIV-Associated NCI in Persons Without Obvious Confounding Conditions

Depression: Screening

Treatment of Chronic HBV in Persons With HBV/HIV Coinfection

Management of Persons With Chronic HCV/HIV Coinfection

HCV Treatment Options in HCV/HIV Coinfected Persons

OI Section

Non-Tuberculosis Mycobacteria (NTM)

Progressive Multifocal Leukoencephalopathy

Temporal Evolution of CD4 Criteria to Initiate ART in Asymptomatic HIV+ Adults (1996-2015) (IAS, DHHS, EACS and WHO ART Guidelines)

Comparing Preferred and Alternative First-line ART Options (DHHS, IAS, EACS, and WHO ART Guidelines)

Conclusions

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

Abbreviations (cont)